← Browse by Condition
Medical Condition

myeloproliferative neoplasm not otherwise specified

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04282187 Phase 2
Recruiting

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Enrollment
25 pts
Location
United States
Sponsor
University of Washington
View Trial →